Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

RSS icon
cancer disparities health equity

In a national survey, 89% of cancer centers report drug shortages

Respondents said supply chain issues are running afoul of prior authorization requirements, leading to delays in patient care. 

Thumbnail

Fluorinated contrast agents show 'strong potential' for MRI theranostics

Experts have developed a first-of-its-kind fluorinated contrast agent they believe will provide more detailed MR imaging and aid in the treatment of certain cancers. 

colorectal cancer colon CTC CRC colonoscopy

Radiology's role in colorectal cancer care set to grow following 'groundbreaking' trial results

The results were so conclusive that the trial was halted at halftime for having met predefined stopping rules. 

Lung cancer screening CT image in a 66-year-old male patient shows a sessile nodule with internal air in the left mainstem to left upper lobe bronchus (arrow) with a mean diameter of 10 mm. The nodule was assigned as Lung-RADS category 4A in the clinical report. (B) Follow-up CT image shows the lesion is resolved. Image courtesy of RSNA

Lung-RADS update helps limit false-positive results, unnecessary procedures

Using the latest version was associated with improved diagnostic accuracy, researchers wrote in a new analysis. 

time-delayed MRI phases improve brain tumor visualization

Using multiple MRI phases after contrast injection significantly improves visualization of brain tumors

Researchers are proposing making additional phases beyond the 10-minute mark mandatory when analyzing brain metastases.

A newly identified PET imaging biomarker could help providers tailor immunotherapy treatments for patients with certain types of cancers.

Researchers identify new PET imaging biomarker capable of predicting immunotherapy success

A newly identified PET imaging biomarker could help providers tailor immunotherapy treatments for patients with certain types of cancers. 

Whole-body maximum-intensity projections over time after [68Ga]Ga-DPI-4452 administration.

New PET agent offers 'exceptional' imaging of kidney cancer

The agent was found to be better than standard CT imaging for patients with clear cell renal cell cancer.

Imaging agent that targets deadly brain tumors given FDA's Fast Track designation

Fast Track designations are typically granted to drugs that target an unmet medical need. 

Displaying 41 - 48 of 416
Design by Adaptive Theme